The Board of Rui Kang Pharmaceutical Group Investments Limited announced that a total of three proposed Directors had been nominated by the Genius Lead Limited to the Board. Mr. Liu Xiaolin and Mr. Wang Zheng will be appointed as executive Directors and Mr. Yan Guoxiang will be appointed as independent non-executive Director with effect from 7 August 2017. Mr. Liu is currently the partner of an investment company, which is mainly engaged in investments in the PRC and Hong Kong. From February 2008 to October 2014, Mr. Liu was a partner and chief mainland China representative in an international private equity fund. Mr. Wang, is currently an independent financial consultant. Prior to becoming an independent financial consultant, Mr. Wang was the audit manager of KPMG Singapore, the deputy general manager of China Everbright Water Limited and also the chief financial officer of SkyNet Group Limited. Mr. Yan is currently the general manager of Shenzhen Junxing Information Technology Co. Ltd. Mr. Yan possesses over 20 years of experience in accounting and management. He was a partner of Da Hua Certified Public Accountants from March 2012 to December 2014. He has also been a visiting professor of the accounting school of Jiangxi University of Finance and Economics since May 2013.